How eHave is Quietly Building a Leading EHR Platform

The medical software industry is ripe for innovation. Unfortunately, many providers still use paper forms or outdated EHR platforms to manage patient billing and health records. The good news is that newer EHR platforms are popping up to address critical shortcomings, particularly in niche markets where conventional EHR platforms don’t fit the bill.

Let’s look at EHR challenges facing the mental health profession and how Ehave Inc. (OTC: EHVVF) aims to overcome them with its innovative EHR platform.

Also: Download the company’s investor presentation and receive corporate updates.

Why EHRs Matter

Data sharing is a common frustration among health care providers given strict patient confidentiality laws and many points of contact.

Electronic health records, or EHRs, are digital versions of a patient’s paper chart. While these records contain medical and treatment histories, they typically go beyond standard clinical data to provide a broad view of a patient’s care. The goal is to automate and streamline provider workflow while making it easy to access information to support medical decisions.

Unfortunately, most EHRs aren’t built for mental health patients and providers. For example, therapists often record sessions or take notes, and most EHRs don’t provide an easy way to search these notes. At the same time, psychedelics and other emerging mental health treatments may not fit neatly into conventional health records.

Ehave’s Dashboard

Ehave built an extensible EHR platform to address these issues with powerful, condition-specific applications.

Like most EHR platforms, Ehave Dashboard is HIPAA compliant, but it goes beyond compliance to provide other key data advantages. For example, the platform leverages blockchain technology to create highly secure and immutable health records that are easy to access, share, and e-sign with transparent tracking along the way.

The platform also makes it easy to search medical records, including video and audio transcripts, using natural language processing—or NLP. Using machine learning algorithms, NLP can isolate the most common keywords, detect the main topics, collect prescription medications, and make it easy to search these data points via text input.

Building an Ecosystem

Ehave’s EHR platform fits hand-in-hand with its other innovative software tools to improve mental health diagnostics and treatments.

Also see: Ehave Looks to Power the Psychedelics Revolution

The company partnered with Vastminz to develop an AI-powered computer vision technology capable of identifying physiological conditions, such as heart rate, heart rate variability, respiration rate, oxygen saturation, and other vital statistics via a mobile phone. These capabilities could help patients report more data from their homes.

In addition, the company signed a letter of intent to acquire Moksha Digital, a medical imaging software provider with seven major hospitals as clients. The move could add medical image sharing capabilities and other reports to its EHR system to bolster its potential further. The seven significant clients could also become users of its EHR platform.

Looking Ahead

Ehave Inc.’s (OTC: EHVVF) EHR platform provides critical solutions for mental health providers and patients. However, the company’s software business represents just one of its many areas of focus. For instance, the company’s KetaDASH platform partners with existing ketamine clinics to provide DoorDash-like services for mental health patients.

Don’t forget: Download the company’s investor presentation and receive corporate updates.

The company also hired a contract research organization, or CRO, to design clinical trials and start collecting certain data points to understand how ketamine can potentially resolve issues in the brain through a process known as neuroplasticity. These kinds of clinical trials could be managed with its dashboard and telemetry tools.

Investors may want to keep an eye on Ehave as it continues to build out its EHR platform and integrate it with other areas of its business. For instance, KetaDASH’s network of ketamine clinics could be a key end market for its innovative EHR platform. These kinds of cross-selling opportunities could unlock a lot of long-term synergies.

For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.